首页> 美国卫生研究院文献>other >Quantitative Multimodal Evaluation of Passaging Human Neural Crest Stem Cells for Peripheral Nerve Regeneration
【2h】

Quantitative Multimodal Evaluation of Passaging Human Neural Crest Stem Cells for Peripheral Nerve Regeneration

机译:传代人类神经C干细胞对周围神经再生的定量多峰评估。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Peripheral nerve injury is a major burden to societies worldwide, however, current therapy options (e.g. autologous nerve grafts) are unable to produce satisfactory outcomes. Many studies have shown that stem cell transplantation holds great potential for peripheral nerve repair, and human neural crest stem cells (NCSCs), which give rise to a variety of tissues in the peripheral nervous system, are particularly promising. NCSCs are one of the best candidates for clinical translation, however, to ensure the viability and quality of NCSCs for research and clinical use, the effect of in vitro cell passaging on therapeutic effects need be evaluated given that passaging is required to expand NCSCs to meet the demands of transplantation in preclinical research and clinical trials. To date, no study has investigated the quality of NCSCs past the 5th passage in vivo. In this study, we employed a multimodal evaluation system to investigate changes in outcomes between transplantation with 5th (p5) and 6th passage (p6) NCSCs in a 15mm rat sciatic nerve injury and repair model. Using CatWalk gait analysis, gastrocnemius muscle index, electrophysiology, immunohistochemistry, and histomorphometric analysis, we showed that p6 NCSCs demonstrated decreased cell survival, Schwann-cell differentiation, axonal growth, and functional outcomes compared to p5 NCSCs (all p<0.05). In conclusion, p6 NCSCs showed significantly reduced therapeutic efficacy compared to p5 NCSCs for peripheral nerve regeneration.
机译:周围神经损伤是全世界社会的主要负担,但是,当前的治疗选择(例如自体神经移植)不能产生令人满意的结果。许多研究表明,干细胞移植在周围神经修复方面具有巨大潜力,而在周围神经系统中产生多种组织的人神经c干细胞(NCSC)尤其有前途。 NCSC是进行临床翻译的最佳人选之一,但是,为了确保NCSC的可行性和质量以供研究和临床使用,考虑到需要传代以扩大NCSC以满足其需要,因此需要评估体外细胞传代对治疗效果的影响。临床前研究和临床试验中对移植的需求。迄今为止,尚无任何研究对体内第5次传代后NCSC的质量进行研究。在这项研究中,我们采用了一种多模式评估系统,以研究在15mm大鼠坐骨神经痛中第5次(p5)和第6次(p6)传代(p6)NCSC移植之间的结局变化神经损伤和修复模型。使用CatWalk步态分析,腓肠肌指数,电生理学,免疫组织化学和组织形态学分析,我们发现p6 NCSC与p5 NCSC相比,细胞存活率,雪旺氏细胞分化,轴突生长和功能结局降低(所有p <0.05)。总之,与p5 NCSC相比,p6 NCSC对周围神经再生的治疗效果显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号